3WD.F KANABO GROUP PLC LS-025
- Market cap
- EUR 316K
- P/E
- -
- P/B
- 0.05x
- ROE
- -106.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2023.
Is 3WD.F undervalued?
Graham numberThe Graham number of KANABO GROUP PLC LS-025 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
KANABO GROUP PLC LS-025 fundamental analysis
No fundamental analysis for KANABO GROUP PLC LS-025 yet.
KANABO GROUP PLC LS-025 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About KANABO GROUP PLC LS-025
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It…
Full company profileKANABO GROUP PLC LS-025 financial statements
KANABO GROUP PLC LS-025 annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 73.0K | 603K | 895K |
| Gross Profit | 7.00K | 199K | 134K |
| Operating Income | -2.80M | -6.07M | -3.00M |
| EBITDA | -4.54M | -5.77M | -6.49M |
| Net Income | -4.55M | -6.87M | -7.99M |
| EPS | -0.01 | -0.02 | -0.01 |
| Balance Sheet | |||
| Total Assets | 5.60M | 14.5M | 8.35M |
| Total Liabilities | 415K | 2.01M | 849K |
| Shareholders' Equity | 5.18M | 12.4M | 7.51M |
| Cash & Short-term Investments | 4.48M | 3.20M | 1.68M |
| Cash Flow | |||
| Operating Cash Flow | -2.08M | -3.78M | -2.52M |
| Capital Expenditure | 35.0K | 153K | 533K |
| Free Cash Flow | -2.11M | -3.93M | -3.05M |
| Ratios | |||
| ROE | -87.8% | -55.2% | -106.3% |
| ROA | -81.3% | -47.5% | -95.6% |
| Net Profit Margin | -6,234.2% | -1,138.8% | -892.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
KANABO GROUP PLC LS-025 dividends
KANABO GROUP PLC LS-025 has not paid dividends in the last 3 fiscal years.
Who owns KANABO GROUP PLC LS-025
- Insiders 3.43%
- Institutions 0.05%
- Public & others 96.53%
- Shares outstanding 632M
- Free float 379M
KANABO GROUP PLC LS-025 company profile
- Company name
- KANABO GROUP PLC LS-025
- Ticker
- 3WD.F
- ISIN
- GB00BYQCS703
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 20
- Fiscal year end
- December
- Address
- Churchill House, London, United Kingdom, NW4 4DJ
- Website
- kanabogroup.com
About KANABO GROUP PLC LS-025
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.
KANABO GROUP PLC LS-025 management
4- Mr. Avihu TamirCEO, Executive Director & Secretary · born 1981
- Mr. David SackCo-founder
- Mr. Assaf VardimonChief Financial Officer · born 1978
- Mr. Suleman SacranieChief Technology Officer